Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
Clinical trial NCT03900949 · COMPLETED
Trial details
- NCT number
- NCT03900949
- Sponsor
- Uma Borate
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2024-08-08
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.